6 July 2021 - The UK’s Medicines and Healthcare products Regulatory Agency has revealed its new delivery plan, outlining its two-year strategy after departing from the European regulatory system.
The delivery plan, spanning 2021-2023, is aiming to ‘put patients first’ after the Independent Medicines and Medical Devices Safety review revealed a ‘failure to listen to and respond to patients’.